Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

AS Info Share

When a treatment doesn't work, you didn't fail.

14 Jul 2025

Description

If a treatment didn’t work, you didn’t fail.In this episode of AS Info Share, we explore why it’s common for people with Axial Spondyloarthritis (AxSpA) / Ankylosing Spondylitis (AS) to feel like they’ve “failed” a medication, and why that mindset needs to change. Whether you’re on your first medication or your fifth, this episode is a reminder that you’re not alone.----------------------------------------------------------------------------📲 Follow & Support AS Info ShareStay connected for more tips, support, and science-backed info about ankylosing spondylitis:🌐 Websitehttps://asinfoshare.com📘 Facebookhttps://www.facebook.com/share/1FsvU3r8du/?mibextid=wwXIfr📷 Instagramhttps://www.instagram.com/as_info_share?igsh=YjBxdDYxYjAwNXlm&utm_source=qr🐦 X (formerly Twitter)https://x.com/asinfoshare?s=21&t=1W8OEkJfbunr_bpIeiSSJw▶️ YouTubehttps://youtube.com/@ASInfoShare?si=QhKU8Kk6jCHCOPUV☕ Support Our Workhttps://buymeacoffee.com/asinfoshare💬 Leave a comment 📌 Subscribe for more helpful videos on ankylosing spondylitis, natural therapies, and support for chronic inflammation.🔔 Tap the bell to stay updated!----------------------------------------------------------------------------#AnkylosingSpondylitis #AxSpA #axialSpondyloarthritis #biologics #Inflammation #ArthritisRelief #backpain #rheumatology #inflammatorydisease #autoimmunedisease #ASInfoShare----------------------------------------------------------------------------https://www.youtube.com/playlist?list=PLwXNdEGKZCMt0kJHYfUUwfpHGW1ELEvQ7 Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.